FEATURES: CEErectile Dysfunction: A panel's recommendations for management.Lewis, Jean H. BSN, RN, CNP; Rosen, Raymond PhD; Goldstein, Irwin MDConsensus Panel on Health Care Clinician Management of Erectile DysfunctionAuthor Information The panel was cochaired by Jean H. Lewis, past president, Society of Urologic Nurses and Associates, and coordinator of the erectile dysfunction clinic at the Veteran's Affairs Medical Center in Minneapolis; Irwin Goldstein, MD, director, Center for Sexual Medicine at Boston University School of Medicine; and Raymond Rosen, director, Program in Human Sexuality, UMDNJ–Robert Wood Johnson Medical School. The panel members were Jeffrey Albaugh, MS, APRN,BC, CUCNS; Ira Amargo, MSN, RN, CFNP; Roberta Capelson, NP; Elizabeth Flaherty, RN; Christopher Forest, PA-C; Irwin Goldstein, MD; Penny Kaye Jensen, MS, APRN-BC, FNP; Kathryn Jones, MSN, RN; Robert Kloner, PhD, MD; Barbara Lawrie, BSN, RN, CRRN; Jean H. Lewis, BSN, RN, CNP; Stephanie Mullin, BSN, RN, PHN; Terry Payton, BS, RN; Raymond Rosen, PhD; Richard Sadovsky, MD; Kenneth Snow, MD; Dan Vetrosky, MEd, PA-C. The Consensus Panel on Health Care Clinician Management of Erectile Dysfunction convened in September 2001 and was sponsored by the University of Medicine and Dentistry of New Jersey (UMDNJ)–Robert Wood Johnson Medical School in Newark. Funding was provided by an unrestricted educational grant from Bayer Pharmaceuticals, the manufacturer of Levitra, a drug mentioned in this article. Contact author, Jean H. Lewis: [email protected]. Author disclosures: Jean H. Lewis cochaired this consensus panel and was paid an honorarium through a grant to the University of Medicine and Dentistry of New Jersey and the Robert Wood Johnson Foundation by Bayer, Inc. (the manufacturer of Levitra, a drug mentioned in this article). She has been paid by Bayer, Inc., Lilly ICOS (the manufacturer of Cialis, a drug mentioned in this article), and Pfizer, Inc. (the manufacturer of Viagra, a drug mentioned in this article) to speak at several nursing conferences and also serves on a primary care advisory board for Lilly ICOS. Raymond Rosen has worked as a paid consultant and researcher for Pfizer, Inc., and has been paid to conduct research for Bayer, Inc., and Lilly ICOS. Irwin Goldstein has consulted and served on an advisory panel for and received research grants from Pfizer, Inc., Bayer, Inc., Lilly ICOS, Mentor Corporation (a manufacturer of penile implants, a treatment mentioned in this article), and American Medical Systems (a manufacturer of penile prostheses, a treatment mentioned in this article). AJN, American Journal of Nursing: October 2003 - Volume 103 - Issue 10 - p 48-57 Buy SDC Take the CE Test In Brief The definition of the disorder is so broad that it's difficult to estimate the number of men with erectile dysfunction. Between 15 million and 30 million American men are affected by it, and each can choose from a number of treatment options. © 2003 Lippincott Williams & Wilkins, Inc.